Single-Nuclei Transcriptomic Profiling of Human Myocardium in Long-Chain 3-Hydroxyacyl-Coenzyme A Dehydrogenase Deficiency
Summary
No summary yet. VIRAT can read this paper and write a plain-language summary of its aim, methods, key findings and limitations.
Summarise with VIRAT Free to try with your Science Catalogs account.Abstract
Long chain 3-hydroxyacyl-coenzyme A dehydrogenase deficiency (LCHADD) is a rare metabolic disorder that leads to disordered fatty acid oxidation.LCHADD presents as infantile cardiomyopathy in approximately 30% of patients, whom often will go on to develop heart failure (HF) or sudden cardiac arrest.(1)Although early diagnosis, dietary modification, and genotype affects outcomes, the cardiac molecular phenotype remains less understood.A LCHADD patient presented with transient HF at 1 month of life with prototypical symptoms including lactic acidosis and hypoglycemia (Figure 1A).His newborn screen exhibited elevation in long chain fatty acids and genetic testing revealed a pathogenic variant (E510Q) in HADHA.Throughout childhood, he experienced rhabdomyolysis, vomiting, and diarrhea, sometimes accompanied by left ventricle (LV) dysfunction requiring inotropic support.Following three presentations of severe HF at age 14 years, heart transplantation (HTx) was performed due to frequency of HF recurrence.He remained on milrinone for 5 months and normalized function, brain natriuretic peptide, and LV size at time of HTx.
Fields of Study & Subjects
Metabolism and Genetic Disorders
Cardiomyopathy and Myosin Studies
Cardiovascular Function and Risk Factors
Publication details
- Journal / source
- Circulation Heart Failure
- Volume
- 19
- Issue
- 5
- Pages
- e014092–e014092
- Publication date
- 31 March 2026
- Language
- EN